Roche to Invest $2 Billion in North Carolina Facility

Roche's Genentech will double its North Carolina investment to $2 billion, expanding a facility in Holly Springs to produce obesity treatments and create 2,000 jobs.

洞察:
Roche's Genentech announced on January 20, 2026, that it will more than double its initial investment in a biomanufacturing facility in North Carolina to approximately $2 billion. This significant increase from the previous commitment of over $700 million, made in May 2025, underscores the company's strategic focus on expanding its manufacturing capabilities in the United States.
The logo of Swiss pharmaceutical company Roche is displayed at their headquarters in Basel, Switzerland, on January 28, 2016. REUTERS/Arnd Wiegmann
The logo of Swiss pharmaceutical company Roche is displayed at their headquarters in Basel, Switzerland, on January 28, 2016. REUTERS/Arnd Wiegmann